Phosphagenics Limited (ASX: POH; AIM: PSG; OTC/ADR: PPGNY) (“Phosphagenics”) announced today that its company information would be made available via Standard & Poor’s Corporation Records Listing Program. As part of the program, a full description of Phosphagenics will be published in the Daily News Section of Standard Corporation Records, a recognized securities manual for secondary trading in approximately 38 US states under the Blue Sky Laws.

Standard Corporation Records is available in print, CD-ROM, and via the Web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.

The company information about Phosphagenics to be made available through this program includes an in-depth description of Phosphagenics’ business operations, share price, dividend history, shares outstanding, company financial position, earnings, and full income statement and balance sheet.

ENDS….
 

APPENDIX AND NOTES TO EDITORS

About Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics’ core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics’ shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR – Level 1 program has been established in the US with the Bank of New York Mellon (PPGNY) for US investors to trade in Phosphagenics’ stock on the ‘over-the-counter’ market.

The ADR program was launched in March 2006. Participation in Standard & Poor’s Records Listing Program will allow brokerage and investment firms to actively promote PPGNY in as many as 38 US states, thereby potentially increasing liquidity. Without coverage such as that provided by this program, under state securities or “blue sky” laws, brokers would only be permitted to respond to calls from investors. The listing is also a part of the process that will qualify PPGNY for participation in the new OTCQX International Prime program, a program which commenced trading in March 2007.

For more information, please visit Phosphagenics’ web site at www.phosphagenics.com

About Standard & Poor's